Prestige Biologics Co., Ltd. (KOSDAQ:334970)
South Korea · Delayed Price · Currency is KRW 2,760.00
-35.00 (-1.25%)
At close: Feb 27, 2026
Prestige Biologics Market Cap
Prestige Biologics has a market cap or net worth of 214.6 billion as of February 27, 2026. Its market cap has decreased by -38.47% in one year.
Market Cap
214.60B
Enterprise Value
297.96B
Revenue
19.24B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,760.00
Market Cap Chart
Since March 11, 2021, Prestige Biologics's market cap has decreased from 613.27B to 214.60B, a decrease of -65.01%. That is a compound annual growth rate of -19.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 214.60B | -9.06% |
| Dec 30, 2025 | 235.98B | -40.12% |
| Dec 30, 2024 | 394.06B | 46.25% |
| Dec 28, 2023 | 269.45B | 46.01% |
| Dec 29, 2022 | 184.55B | -59.28% |
| Dec 30, 2021 | 453.18B | -26.10% |
| Mar 11, 2021 | 613.27B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NIBEC | 364.28B |
| ABION | 284.27B |
| Genome & Company | 221.92B |
| ISU Abxis | 219.48B |
| QuadMedicine | 217.24B |
| Bio Solution | 216.34B |
| Kangstem Biotech | 205.98B |
| Ensol Biosciences | 194.80B |